uniQure N.V. (QURE)
NASDAQ
Market Cap
$213.62M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
723 of 809
Rank in Industry
393 of 445
Largest Insider Buys in Sector
QURE Stock Price History Chart
QURE Stock Performance
About uniQure N.V.
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Insider Activity of uniQure N.V.
Over the last 12 months, insiders at uniQure N.V. have bought $0 and sold $698,703 worth of uniQure N.V. stock.
On average, over the past 5 years, insiders at uniQure N.V. have bought $0 and sold $8.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, uniQure N.V.
| 2024-06-17 | Sale | KLEMT CHRISTIAN | Chief Financial Officer | 1,611 0.003% | $4.80 | $7,733 | -2.77% | |
| 2024-06-17 | Sale | CALOZ PIERRE | Chief Operating Officer | 2,936 0.0056% | $4.81 | $14,122 | -2.77% | |
| 2024-06-13 | Sale | Potts Jeannette | Chief Legal Officer | 4,781 0.0094% | $4.98 | $23,809 | -12.95% | |
| 2024-06-13 | Sale | Gut Robert | director | 3,504 0.0071% | $5.12 | $17,940 | -12.95% | |
| 2024-06-13 | Sale | Balachandran Madhavan | director | 2,231 0.0045% | $5.12 | $11,423 | -12.95% | |
| 2024-06-13 | Sale | Springhorn Jeremy P. | director | 2,231 0.0045% | $5.12 | $11,423 | -12.95% | |
| 2024-06-13 | Sale | Meek David D. | director | 2,229 0.0045% | $5.12 | $11,412 | -12.95% | |
| 2024-06-13 | Sale | Soteropoulos Paula | director | 2,220 0.0045% | $5.14 | $11,411 | -12.95% | |
| 2024-06-13 | Sale | POST LEONARD E | director | 2,222 0.0045% | $5.14 | $11,421 | -12.95% | |
| 2024-06-13 | Sale | Jacques Rachelle Suzanne | director | 2,221 0.0045% | $5.14 | $11,416 | -12.95% | |
| 2024-06-13 | Sale | Kaye Jack | director | 2,218 0.0045% | $5.16 | $11,445 | -12.95% | |
| 2024-02-26 | Sale | Kapusta Matthew C | CEO, Managing Director | 27,904 0.0581% | $6.35 | $177,190 | -21.32% | |
| 2024-02-26 | Sale | KLEMT CHRISTIAN | Chief Financial Officer | 15,906 0.0333% | $6.38 | $101,480 | -21.32% | |
| 2024-02-26 | Sale | CALOZ PIERRE | Chief Operating Officer | 9,455 0.0201% | $6.47 | $61,174 | -21.32% | |
| 2023-09-18 | Sale | Dolmetsch Ricardo | President, R&D | 5,841 0.0124% | $7.46 | $43,574 | -22.45% | |
| 2023-07-10 | Sale | CALOZ PIERRE | Chief Operating Officer | 15,117 0.0313% | $11.36 | $171,729 | -46.49% | |
| 2023-06-16 | Sale | KLEMT CHRISTIAN | Chief Financial Officer | 1,587 0.0033% | $18.94 | $30,058 | -67.56% | |
| 2023-06-16 | Sale | CALOZ PIERRE | Chief Operating Officer | 2,920 0.0059% | $18.80 | $54,896 | -67.56% | |
| 2023-06-16 | Sale | Gut Robert | director | 3,228 0.0066% | $18.88 | $60,945 | -67.56% | |
| 2023-06-16 | Sale | Kaye Jack | director | 2,280 0.0047% | $18.93 | $43,160 | -67.56% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Nantahala Capital Management Llc | $16.06M | 6.36 | 3.09M | +4.4% | +$676,285.98 | 1.65 | |
| 683 Capital Management Llc | $10.27M | 4.07 | 1.98M | +16.66% | +$1.47M | 1.15 | |
| BlackRock | $9.68M | 3.83 | 1.86M | +1.31% | +$124,722.00 | <0.0001 | |
| Morgan Stanley | $7.89M | 3.13 | 1.52M | -13.73% | -$1.26M | <0.01 | |
| Schroder Investment Management Group | $6.46M | 2.56 | 1.24M | 0% | +$0 | 0.01 | |
| The Vanguard Group | $5.58M | 2.21 | 1.07M | +11.4% | +$570,647.98 | <0.0001 | |
| JPMorgan Chase | $5.04M | 2 | 969,504 | +29.38% | +$1.14M | <0.0001 | |
| D. E. Shaw & Co. | $4.42M | 1.75 | 850,100 | +51.71% | +$1.51M | 0.01 | |
| Ameriprise Financial | $3.69M | 1.46 | 709,435 | -13.51% | -$576,289.84 | <0.01 | |
| Macquarie Group | $3.67M | 1.46 | 706,166 | 0% | +$0 | <0.01 | |
| Acadian Asset Management | $3.19M | 1.26 | 613,490 | +133.09% | +$1.82M | 0.01 | |
| Privium Fund Management | $3.01M | 1.19 | 578,915 | +30.34% | +$700,788.40 | 0.88 | |
| Citadel Advisors LLC | $2.86M | 1.13 | 550,567 | +221.89% | +$1.97M | <0.01 | |
| Hudson Bay Capital Management LP | $2.73M | 1.08 | 525,000 | +23.53% | +$520,000.00 | 0.03 | |
| J. Goldman & Company | $2.65M | 1.05 | 510,505 | New | +$2.65M | 0.12 | |
| Susquehanna International Group | $2.62M | 1.04 | 503,883 | +198.64% | +$1.74M | <0.01 | |
| Geode Capital Management | $2.6M | 1.03 | 499,820 | +4.2% | +$104,778.26 | <0.0001 | |
| Millennium Management LLC | $2.47M | 0.98 | 474,579 | +4.2% | +$99,356.41 | <0.01 | |
| Ikarian Capital LLC | $2.44M | 0.97 | 469,133 | +198.12% | +$1.62M | 0.7 | |
| Alphacentric Advisors Llc | $2.39M | 0.95 | 460,000 | +9.26% | +$202,670.00 | 1.52 | |
| Standard Life | $2.08M | 0.83 | 400,480 | 0% | +$0 | <0.01 | |
| Bridger Management Llc | $1.88M | 0.75 | 362,349 | 0% | +$0 | 0.85 | |
| Goldman Sachs | $1.88M | 0.75 | 362,333 | -47.89% | -$1.73M | <0.0001 | |
| Bank of America | $1.64M | 0.65 | 314,457 | +14.4% | +$205,857.68 | <0.0001 | |
| Verition Fund Management Llc | $1.61M | 0.64 | 310,567 | +2.35% | +$37,086.39 | 0.02 | |
| Two Sigma Advisers LP | $1.51M | 0.6 | 289,500 | +922.97% | +$1.36M | <0.01 | |
| PFM Health Sciences | $1.43M | 0.57 | 274,540 | New | +$1.43M | 0.04 | |
| Group One Trading | $1.32M | 0.52 | 254,027 | +405.21% | +$1.06M | 0.04 | |
| Renaissance Technologies | $1.28M | 0.51 | 246,410 | -6.84% | -$94,111.21 | <0.01 | |
| Two Sigma | $1.23M | 0.49 | 236,277 | +93.71% | +$594,365.01 | <0.01 | |
| Charles Schwab | $1.22M | 0.49 | 235,490 | +5.89% | +$68,125.20 | <0.0001 | |
| Carlson Capital, L.P. | $1.18M | 0.47 | 227,400 | +16.61% | +$168,480.00 | 0.12 | |
| Jane Street Capital | $1.12M | 0.44 | 215,669 | +105% | +$574,428.50 | <0.01 | |
| State Street | $1.06M | 0.42 | 203,802 | -94.14% | -$17.03M | <0.0001 | |
| Boothbay Fund Management LLC | $1M | 0.4 | 192,814 | +424.82% | +$811,590.16 | 0.03 | |
| Point72 Asset Management | $963,165.00 | 0.38 | 185,224 | -80.11% | -$3.88M | <0.01 | |
| GHOST TREE CAPITAL LLC | $858,000.00 | 0.34 | 165,000 | 0% | +$0 | 0.28 | |
| Mirae Asset Global Investments Co Ltd | $3.14M | 0.32 | 157,312 | +74.11% | +$1.33M | <0.01 | |
| Tang Capital Management, LLC | $696,389.00 | 0.28 | 133,921 | -77.68% | -$2.42M | <0.01 | |
| Banque Pictet Cie Sa | $687,341.00 | 0.27 | 132,181 | -8.58% | -$64,500.78 | 0.01 | |
| PDT Partners | $633,698.00 | 0.25 | 121,865 | +21.62% | +$112,652.80 | 0.05 | |
| ExodusPoint Capital Management, LP | $607,000.00 | 0.24 | 116,708 | New | +$607,000.00 | 0.01 | |
| Invesco | $564,710.00 | 0.22 | 108,598 | +203.35% | +$378,555.07 | <0.0001 | |
| Jump Financial Llc | $518,315.00 | 0.21 | 99,676 | -8.46% | -$47,871.18 | <0.01 | |
| Northern Trust | $441,501.00 | 0.18 | 84,904 | -2.56% | -$11,601.20 | <0.0001 | |
| Simplex Trading Llc | $439,000.00 | 0.17 | 84,587 | +291.63% | +$326,902.86 | 0.01 | |
| Sigma Planning Corp | $429,806.00 | 0.17 | 82,655 | +187.55% | +$280,332.00 | 0.01 | |
| Walleye Capital | $422,068.00 | 0.17 | 81,167 | -42.34% | -$309,857.31 | <0.01 | |
| Diamond Hill Investment Group Inc | $398,476.00 | 0.16 | 76,630 | +41.42% | +$116,714.00 | <0.01 | |
| Ubs Oconnor Llc | $369,533.00 | 0.15 | 71,064 | -25.2% | -$124,467.27 | 0.03 |